Literature DB >> 35006909

Recent Advances in Nanomaterials Development for Nanomedicine and Cancer.

Abolghasem Abbasi Kajani1, Shaghayegh Haghjooy Javanmard1, Mohsen Asadnia2, Amir Razmjou3,4,5.   

Abstract

Cancer is considered one of the leading causes of death, with a growing number of cases worldwide. However, the early diagnosis and efficient therapy of cancer have remained a critical challenge. The emergence of nanomedicine has opened up a promising window to address the drawbacks of cancer detection and treatment. A wide range of engineered nanomaterials and nanoplatforms with different shapes, sizes, and composition has been developed for various biomedical applications. Nanomaterials have been increasingly used in various applications in bioimaging, diagnosis, and therapy of cancers. Recently, numerous multifunctional and smart nanoparticles with the ability of simultaneous diagnosis and targeted cancer therapy have been reported. The multidisciplinary attempts led to the development of several exciting clinically approved nanotherapeutics. The nanobased materials and devices have also been used extensively to develop point-of-care and highly sensitive methods of cancer detection. In this review article, the most significant achievements and latest advances in the nanomaterials development for cancer nanomedicine are critically discussed. In addition, the future perspectives of this field are evaluated.

Entities:  

Keywords:  cancer therapy; drug delivery; nanomaterials; nanomedicine; nanoparticles

Mesh:

Year:  2021        PMID: 35006909     DOI: 10.1021/acsabm.1c00591

Source DB:  PubMed          Journal:  ACS Appl Bio Mater        ISSN: 2576-6422


  6 in total

1.  Tumor microenvironment responsive Mn3O4 nanoplatform for in vivo real-time monitoring of drug resistance and photothermal/chemodynamic synergistic therapy of gastric cancer.

Authors:  Hanrui Li; Xiaoxia Cai; Tong Yi; Yun Zeng; Jingwen Ma; Lei Li; Liaojun Pang; Na Li; Hao Hu; Yonghua Zhan
Journal:  J Nanobiotechnology       Date:  2022-05-23       Impact factor: 9.429

Review 2.  Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles.

Authors:  Alberto Juan; María Del Mar Noblejas-López; María Arenas-Moreira; Carlos Alonso-Moreno; Alberto Ocaña
Journal:  Front Cell Dev Biol       Date:  2022-02-03

Review 3.  A Nanoparticle's Journey to the Tumor: Strategies to Overcome First-Pass Metabolism and Their Limitations.

Authors:  Joshua J Milligan; Soumen Saha
Journal:  Cancers (Basel)       Date:  2022-03-29       Impact factor: 6.639

4.  Dually Responsive Nanoparticles for Drug Delivery Based on Quaternized Chitosan.

Authors:  Fenghui Qiao; Zhiqi Jiang; Wen Fang; Jingzhi Sun; Qiaoling Hu
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

5.  Riboflavin-citrate conjugate multicore SPIONs with enhanced magnetic responses and cellular uptake in breast cancer cells.

Authors:  Wid Mekseriwattana; Pablo Guardia; Beatriz Torres Herrero; Jesus M de la Fuente; Chutima Kuhakarn; Anna Roig; Kanlaya Prapainop Katewongsa
Journal:  Nanoscale Adv       Date:  2022-03-02

6.  Cholesterol-Inulin Conjugates for Efficient SN38 Nuclear Delivery: Nanomedicines for Precision Cancer Therapy.

Authors:  Nicolò Mauro; Mara Andrea Utzeri; Roberta Cillari; Cinzia Scialabba; Gaetano Giammona; Gennara Cavallaro
Journal:  Cancers (Basel)       Date:  2022-10-04       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.